Multigene predictors of tacrolimus exposure in kidney transplant recipients.
Multigene predictors of tacrolimus exposure in kidney transplant recipients.
复制标题
DOI:
10.2217/pgs.15.42
复制
发表时间:
2015-07
期刊:
影响因子:
2.1
通讯作者:
DeKAF Investigators
中科院分区:
文献类型:
--
作者:
Pulk RA;Schladt DS;Oetting WS;Guan W;Israni AK;Matas AJ;Remmel RP;Jacobson PA;DeKAF Investigators
Determine the effect of the genetic variants beyond CYP3A5*3 on tacrolimus disposition. We studied genetic correlates of tacrolimus trough concentrations with POR*28, CYP3A4*22 and ABCC2 haplotypes in a large, ethnically diverse kidney transplant cohort (n = 2008). Subjects carrying one or more CYP3A5*1 alleles had lower tacrolimus trough concentrations (p = 9.2 × 10−75). The presence of one or two POR*28 alleles was associated with a 4.63% reduction in tacrolimus trough concentrations after adjusting for CYP3A5*1 and clinical factors (p = 0.037). In subset analyses, POR*28 was significant only in CYP3A5*3/*3 carriers (p = 0.03). The CYP3A4*22 variant and the ABBC2 haplotypes were not associated. This study confirmed that CYP3A5*1 was associated with lower tacrolimus trough concentrations. POR*28 was associated with decreased tacrolimus trough concentrations although the effect was small possibly through enhanced CYP3A4 enzyme activity. CYP3A4*22 and ABCC2 haplotypes did not influence tacrolimus trough concentrations.